debu tripathy, md discusses the paloma-2 trial outcomes in er /her2- advanced breast cancer

Published 8 years ago • 82 plays • Length 0:37

Download video MP4
Download video MP3

Similar videos

0:38

debu tripathy, md on the evidence of palbociclib (ibrance) efficacy in the paloma-2 trial
4:17

debu tripathy, md, discusses recent fda approvals and her2 metastatic breast cancer management
0:41

debu tripathy, md, on the use of hormonal therapy in the paloma-2 clinical study
1:29

dr. finn on the phase iii paloma-2 trial in er breast cancer
2:48

debu tripathy discusses a clinical trial of ibrance in breast cancer
6:44

breast cancer review series: dcis and idc
6:54

update post thoracentisis, ibrance cycle 15
6:15

review of ovarian tumor types
8:25

paloma-1 study of palbociclib in er , her2-, breast cancer
1:36

dr. debu tripathy on the cdk4/6 inhibitor pd 0332991 in er-positive advanced breast cancer
1:35

debu tripathy, md provides update on breast cancer treatment algorithms impacted by pd-l1
3:26

updates in er-positive breast cancer by debu tripathy, md
1:56

debu tripathy, md, elaborates on the sophia trial in her metastatic breast cancer
1:24

debu tripathy, md, provides perspective on the treatment of her2 breast cancer patients
2:01

debu tripathy, md, shares the outcomes of the monaleesa-7 in premenopausal metastatic breast cancer
1:18

debu tripathy, md on the importance of cdk4/6 for future breast cancer treatments
1:25

debu tripathy, md explains how liquid biopsy figures into breast cancer treatment
1:40

debu tripathy, md, regarding cdk 4/6 inhibitors in the treatment of breast cancer
3:50

debu tripathy, md, describes the evolving role of parp inhibitors in breast cancer patients
2:26

debu tripathy, md, on presentations pertaining to immunotherapy in early breast cancer treatment
2:27

debu tripathy, md, on how the aphinity study could impact treatment of adjuvant breast cancer
6:38

palbociclib shows improved pfs but not improved os for er her2- mbc patients

Clip.africa.com - Privacy-policy